1. Emily Labriola-Tompkins
Information acquired: 2025
Emily Labriola-Tompkins is an academic who published a paper in 2020-12-14 entitled A Phase 1 study of RO6870810, a novel bromodomain and extra-terminal protein inhibitor, in patients with NUT carcinoma, other solid tumours, or diffuse large B-cell lymphoma. The paper was published in a journal entitled British Journal of Cancer.